Raymond James & Associates Opko Health, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Opko Health, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 38,665 shares of OPK stock, worth $58,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,665
Previous 38,265
1.05%
Holding current value
$58,384
Previous $47,000
21.28%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding OPK
# of Institutions
256Shares Held
186MCall Options Held
6.03MPut Options Held
10.1M-
Rubric Capital Management LP New York, NY48.7MShares$73.5 Million2.02% of portfolio
-
Black Rock Inc. New York, NY29.2MShares$44.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.2MShares$44.1 Million0.0% of portfolio
-
State Street Corp Boston, MA8.72MShares$13.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA8.37MShares$12.6 Million0.0% of portfolio
About OPKO HEALTH, INC.
- Ticker OPK
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 771,960,000
- Market Cap $1.17B
- Description
- OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...